Your browser doesn't support javascript.
loading
The new treatment target of diabetes: islet β-cell mass / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism ; (12)2009.
Article Dans Chinois | WPRIM | ID: wpr-585091
ABSTRACT
Pancreatic islet β-cell mass is regulated by β-cell replication, nengenesis, apnptosis and cell size. β-cetl mass in diahetic patients is conspicuously less than that in normal subjects. Induction of β-cell regeneration and inhibition of β-cell apoptosis is the new target of diabetes treatment.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Endocrinology and Metabolism Année: 2009 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Endocrinology and Metabolism Année: 2009 Type: Article